A Randomized, Double-blind, parallel group, placebo-controlled study investigating the Optimal dose regimen, efficacy, and safety of adding Oral Cyst
Project Description:
Novabiotics, Ltd.
A Randomized, Double-blind, parallel group, placebo-controlled study investigating the Optimal dose regimen, efficacy, and safety of adding Oral Cysteamine in Adult patients with Cystic Fibrosis.
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Adults with Disabilities
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas
Primary Target Audience Geographic Descriptor:
National
COVID-19 Related Data:
N/A